In melanoma, TLR5 is not as well studied as TLR2 or TLR4, but evidence suggests that many cell lines express TLR5 to varying degrees [8], and therefore, innate and adaptive immunity could be activated by TPV/Δ2L/Δ66R/FliC infections in melanoma cells. This evidence concerns the gene TLR4 and melanoma.